Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses.
about
Adverse events post smallpox-vaccination: insights from tail scarification infection in mice with Vaccinia virusProtective Mechanisms Induced by a Japanese Encephalitis Virus DNA Vaccine: Requirement for Antibody but Not CD8+ Cytotoxic T-Cell ResponsesAlveolar macrophages are essential for protection from respiratory failure and associated morbidity following influenza virus infection.Diversity in the acute CD8 T cell response to vaccinia virus in humans.Prevention of peripheral tolerance by a dendritic cell growth factor: flt3 ligand as an adjuvant.The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity In vivo.Perforin is essential for control of ectromelia virus but not related poxviruses in mice.The relative role of lymphocyte granule exocytosis versus death receptor-mediated cytotoxicity in viral pathophysiologyRediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases.Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.B2 but not B1 cells can contribute to CD4+ T-cell-mediated clearance of rotavirus in SCID miceSystemic immunity and mucosal immunity are induced against human immunodeficiency virus Gag protein in mice by a new hyperattenuated strain of Listeria monocytogenesRibavirin and IFN-alpha combination therapy induces CD4+ T-cell proliferation and Th1 cytokine secretion in patients with chronic hepatitis BHumoral immune responses in CD40 ligand-deficient mice.Increased gamma-delta T-lymphocyte response to Mycobacterium bovis BCG in major histocompatibility complex class I-deficient mice.Functions and mechanisms of action of the adenovirus E3 proteins.β2-microglobulin is required for the full expression of xenobiotic-induced systemic autoimmunity.Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice.Immune CD4+ T cells promote the clearance of influenza virus from major histocompatibility complex class II -/- respiratory epitheliumTheiler's virus persistence and demyelination in major histocompatibility complex class II-deficient miceDifferent roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection.Enhanced mucosal and systemic immune responses to intestinal reovirus infection in beta2-microglobulin-deficient mice.Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression.Antigen-specific tumor vaccine efficacy in vivo against prostate cancer with low class I MHC requires competent class II MHC.Comparable polyfunctionality of ectromelia virus- and vaccinia virus-specific murine T cells despite markedly different in vivo replication and pathogenicityMice lacking major histocompatibility complex class I and class II molecules.Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice.Greatly reduced lymphoproliferation in lpr mice lacking major histocompatibility complex class I.T cell-independent antibody-mediated clearance of polyoma virus in T cell-deficient mice.CD4(+) T cell subsets during virus infection. Protective capacity depends on effector cytokine secretion and on migratory capability.Beta2-microglobulin-deficient mice are resistant to bullous pemphigoid.CD8 T cells are essential for recovery from a respiratory vaccinia virus infection.Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects.Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responsesVaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity.Immunity and immunological memory following smallpox vaccination.Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice.Antiviral immune responses of lymphocytic choriomeningitis virus-infected mice lacking CD8+ T lymphocytes because of disruption of the beta 2-microglobulin gene.Divergence between cytotoxic effector function and tumor necrosis factor alpha production for inflammatory CD4+ T cells from mice with Sendai virus pneumonia.JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody
P2860
Q27346800-4F213230-0492-4260-9597-1432CED40B73Q27469884-E5EBF889-5AE2-4ED0-8FA8-188D082913CEQ31157006-427D4CE5-9C23-4749-8A66-1BC0C3D933F2Q33227607-6FDF2539-57A8-48A5-BC62-941AA9A685DBQ33368912-DF60CD7E-F62B-4FFA-8D69-C860B44D1809Q33641693-691D7F1B-7F92-4629-93A9-8B1BBA056284Q33642366-D440434D-149E-42E7-A63C-3CCF729DA8CEQ33781851-7603C1B1-3971-4D2A-89AD-B00193AC3AF1Q33799767-A10658DA-44EA-458D-8489-C5584B7CC8EBQ33836059-C3F1C1E2-8050-4D74-B91C-0AA67E948AB9Q33841875-A0A613EB-BFE0-4986-9D61-B65193B25576Q33865731-80FA5386-CE00-4B6E-A18C-72FD2B2B6810Q34225464-1F3EEA41-405A-48FB-8F20-E85BCFD9CDFCQ34725239-D25CF622-A72D-41DF-A017-2D5B92DCC2E8Q35419687-FD84D0A4-EDA9-49C4-B848-0A75370F7E24Q35613800-497BB75B-E92F-4284-BFBD-19E87C61AA3EQ35671513-6DBFF2C6-1448-49AF-B0F3-BF2D93770168Q35852251-7417FEC9-1578-4E27-B289-F69BDCF51987Q35855596-6EA1FAE6-A232-4D67-B2FF-1CF314A882CBQ35856874-CC75E934-0230-4A68-A917-EE69BC0C9B21Q35873118-7DF8954F-561B-4A5A-8FFC-4BC29763607DQ35889536-879DD2FE-8C02-4CB3-9865-A911DB79DBF0Q36051171-378EFB55-0AD5-4CB6-BDAB-BBAA609C087DQ36093442-EDDAE399-046C-4284-A5A9-9D2F037EF9A6Q36155548-FA56AF1C-1A65-44F1-81B4-95F1B77BCF02Q36271130-D8B513AA-4FE4-4B87-9790-F8129062A897Q36362549-8271146D-AF1D-4342-8B3C-95030AEB10A1Q36364361-2D4EE28F-0AB5-4645-AB91-F3D46E3FA5DCQ36366211-7C173AFA-6528-48B7-9579-C48B40FD79D1Q36368586-3FF51FAF-7AAC-453E-9FE0-5596849B57B7Q36380468-1F9EFB79-EC66-4369-AA68-B8C65980DB4CQ36394928-4B3B3CD7-02A5-42F9-98DE-64CA63264EADQ36401305-FDF2528E-60B3-4099-825E-FA5C04505E02Q36401349-DA267AAB-D355-45CB-8249-38210137CA56Q36464830-A1CA40C0-E3F5-4404-9021-F0179F2DF431Q36529039-ADD5DFC3-7296-4754-A4A0-500BE47E6857Q36623371-1FA13BCB-3C5F-4C7F-A460-E3032E501D5FQ36639479-92012B8B-357B-4341-B29C-A07DF9F478A5Q36653976-0073802F-2F94-4ED6-AA4D-84076F4FEAD9Q36760059-5F1ED557-F221-4B27-8DFF-077EBC36AFF5
P2860
Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1992
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Beta 2-microglobulin-, CD8+ T- ...... exhibit altered IgG responses.
@en
Beta 2-microglobulin-, CD8+ T- ...... exhibit altered IgG responses.
@nl
type
label
Beta 2-microglobulin-, CD8+ T- ...... exhibit altered IgG responses.
@en
Beta 2-microglobulin-, CD8+ T- ...... exhibit altered IgG responses.
@nl
prefLabel
Beta 2-microglobulin-, CD8+ T- ...... exhibit altered IgG responses.
@en
Beta 2-microglobulin-, CD8+ T- ...... exhibit altered IgG responses.
@nl
P2093
P2860
P356
P1476
Beta 2-microglobulin-, CD8+ T- ...... exhibit altered IgG responses.
@en
P2093
Fanslow WC
Maliszewski CR
Morrissey PJ
Smithies O
Spriggs MK
P2860
P304
P356
10.1073/PNAS.89.13.6070
P407
P577
1992-07-01T00:00:00Z